Target intelligence / Profile preview

Mas-related G protein-coupled receptor D (MrgD)

Target
MrgD
Molecular classification
G protein-coupled receptor (GPCR), Class A (Rhodopsin-like) GPCR, Orphan receptor (historically; now with identified endogenous ligands)
01

Overview

Mas-related G protein-coupled receptor D (MrgD or MRGPRD) is a member of the Mas-related GPCR family expressed primarily in small-diameter sensory neurons, especially dorsal root ganglion (DRG) neurons, and found in other tissues such as retina and heart. MrgD is activated by endogenous ligands including β-alanine and alamandine, triggering Gi protein-coupled signaling that regulates nociception (pain and itch), vascular tone, and responses to tissue injury. Recent structural studies have elucidated its unique activation mechanism, which may be both ligand-dependent (e.g., β-alanine binding) and constitutive. MrgD and its ligands are implicated in the modulation and potential treatment of neuropathic pain, cardiovascular remodeling, and retinal neurovascular dysfunction, making it a promising, albeit still experimental, therapeutic target.

Other names
MrgDMRGPRDMas-related GPRDMas-related G protein–coupled receptor d
02

Mechanism of action

Agonists (e.g., β-alanine, alamandine): activate MrgD, leading to Gi protein signaling and downstream effects such as modulation of neuronal excitability or attenuation of proinflammatory pathways. Antagonism or genetic deletion: may reduce pain signaling or prevent maladaptive cardiac or retinal remodeling

03

Biological functions

Signal transductionRegulation of pain and itch sensation (nociception)Neuromodulation in dorsal root ganglion neuronsModulation of cardiovascular and retinal homeostasisAnti-inflammatory and anti-oxidative responses in certain tissues
04

Disease associations

Neuropathic painDiabetic peripheral neuropathyCardiovascular disease, including cardiac hypertrophy/remodelingRetinal diseases (neurovascular dysfunction)Inflammatory processes
05

Safety considerations

Potential impact on heart and retinal function if inhibited or over-activated long-termNot yet fully understood; preclinical research is ongoing
06

Interacting drugs

β-alanine (endogenous agonist)

2 more in the full profile.

07

Biomarkers

Expression of MrgD in dorsal root ganglion (DRG) neurons for neuropathic painUpregulation in cardiac and retinal tissue under pathological conditionsNo established circulating or soluble biomarker in clinical use

Beyond the preview

Go deeper on Mas-related G protein-coupled receptor D (MrgD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mas-related G protein-coupled receptor D (MrgD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call